Product Description
CJC-1295 DAC binds to circulating albumin, extending its plasma half-life to approximately 6–8 days, allowing less frequent dosing in experimental models.
Effectively increases pulsatile GH release, which in turn elevates insulin-like growth factor-1 (IGF-1) levels, supporting studies of growth, metabolism, and tissue repair.
By promoting GH/IGF-1 axis activity, it facilitates investigations into skeletal muscle hypertrophy, tendon repair, and connective tissue regeneration.
CJC-1295 DAC is frequently used in research on age-related decline in GH production, helping to study metabolism, body composition, and cellular rejuvenation.
Lyophilized, purified form ensures reproducible activity in vitro and in vivo, making it suitable for long-term experimental studies.
| Parameter | Description |
| CAS Number | 154947-66-7 |
| Product Name | CJC-1295 DAC |
| Molecular Formula | C₁₀₁H₁₆₆N₃₂O₂₀ |
| Molecular Weight | 4,329.08 Da |
| Amino Acid Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ |
| Appearance | White to off-white lyophilized powder |
| Storage | –20°C, protected from light and moisture |
| Specification | Option |
| Purity | ≥98% (HPLC) |
| Form | Lyophilized powder |
| Vial Sizes | 1 mg, 2 mg, 5 mg, 10 mg (custom packaging available) |
| Packaging | Sterile sealed vials, moisture-resistant, temperature-controlled |
| Shelf Life | 24 months under recommended storage conditions |
1. Endocrinology & GH Axis Research: Used to study growth hormone regulation, IGF-1 signaling, and pituitary gland function.
2. Muscle Growth & Regeneration Studies: Supports research on skeletal muscle hypertrophy, connective tissue repair, and rehabilitation models.
3. Metabolic & Anti-Aging Research: Explores effects on body composition, fat metabolism, and age-related decline in GH secretion.
4. Tissue Repair & Regenerative Medicine: Facilitates research in wound healing, tendon regeneration, and cellular growth processes.
5. Peptide Therapeutic Development: Serves as a model for designing long-acting GHRH analogs and sustained-release peptide therapeutics.